Alcohol consumption and not metabolic abnormalities is associated with increased hepatocellular carcinoma risk in patients with End-Stage Liver Disease

被引：0
|
作者：
Tamimi, Tarek I. Abu-Rajab
Hanouneh, Ibrahim A.
Hazin, Ribhi
Lopez, Rocio
Zein, Nizar N.
机构：
来源：
GASTROENTEROLOGY | 2008年 / 134卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A824 / A824
页数：1
相关论文
共 50 条
  • [41] Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma
    Haagsma, EB
    Smit, GPA
    NiezenKoning, KE
    Gouw, ASH
    Meerman, L
    Slooff, MJH
    [J]. HEPATOLOGY, 1997, 25 (03) : 537 - 540
  • [42] The Effect of Model for End-Stage Liver Disease 3.0 on Disparities between Patients with and without Hepatocellular Carcinoma in Korea
    Kim, Kunhee
    Kim, Deok-Gie
    Lee, Jae Geun
    Joo, Dong Jin
    Lee, Hye Won
    [J]. YONSEI MEDICAL JOURNAL, 2023, 64 (11) : 647 - 657
  • [43] Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
    Kim, Jeong Han
    Kim, Ji Hoon
    Choi, Jong Hwan
    Kim, Chung Ho
    Jung, Young Kul
    Yim, Hyung Joon
    Yeon, Jong Eun
    Park, Jong-Jae
    Kim, Jae Seon
    Bak, Young-Tae
    Byun, Kwan Soo
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2009, 44 (03) : 346 - 357
  • [44] Interleukin-6 Polymorphisms and Gender: Relationship with the Occurrence of Hepatocellular Carcinoma in Patients with End-Stage Liver Disease
    Falleti, Edmondo
    Fabris, Carlo
    Toniutto, Pierluigi
    Fontanini, Elisabetta
    Cussigh, Annarosa
    Bitetto, Davide
    Fumolo, Elisa
    Fornasiere, Ezio
    Bragagnini, Walter
    Pinato, David J.
    Minisini, Rosalba
    Pirisi, Mario
    [J]. ONCOLOGY, 2009, 77 (05) : 304 - 313
  • [45] Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinoma
    Hong, Ying-Fen
    Chen, Zhan-Hong
    Ma, Xiao-Kun
    Li, Xing
    Wu, Dong-Hao
    Chen, Jie
    Dong, Min
    Wei, Li
    Wang, Tian-Tian
    Ruan, Dan-Yun
    Lin, Ze-Xiao
    Wen, Jing-Yun
    Lin, Qu
    Jia, Chang-Chang
    Wu, Xiang-Yuan
    [J]. TUMOR BIOLOGY, 2016, 37 (04) : 5265 - 5273
  • [46] Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma Patients
    Tang, Justin Y.
    Ohri, Nitin
    Kabarriti, Rafi
    Aparo, Santiago
    Chuy, Jennifer
    Goel, Sanjay
    Schwartz, Jonathan M.
    Kinkhabwala, Milan
    Kaubisch, Andreas
    Guha, Chandan
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 2018
  • [47] Mortality in patients with end-stage liver disease above model for end-stage liver disease 3.0 of 40
    Tarlow, Branden D.
    Kim, W. Ray
    Mannalithara, Ajitha
    Kwo, Paul Y.
    Bonham, C. Andrew
    Kwong, Allison
    [J]. HEPATOLOGY, 2023, 77 (03) : 851 - 861
  • [48] Use of Model for End-stage Liver Disease (MELD) Score as a Prognostic Factor in Patients with Hepatocellular Carcinoma (HCC)
    Rzouq, Fadi
    Hatoum, Hilana
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S141 - S141
  • [49] Patients With Hepatocellular Carcinoma Have Highest Rates of Wait-listing for Liver Transplantation Among Patients With End-Stage Liver Disease
    Goldberg, David
    French, Benjamin
    Newcomb, Craig
    Liu, Qing
    Sahota, Gurvaneet
    Wallace, Anna E.
    Forde, Kimberly A.
    Lewis, James D.
    Halpern, Scott D.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (11) : 1638 - +
  • [50] Prehabilitation for Patients With End-Stage Liver Disease
    Derck, Jordan
    Klemptner, Emilie
    Mazurek, Alyssa
    Fakhoury, Joseph
    Sonnenday, Christopher
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 : 99 - 99
12345